FDA clears Beckman Coulter Life Sciences AQUIOS STEM System
Beckman Coulter Life Sciences, has received 510(k) clearance from (FDA) for AQUIOS STEM System for Stem Cell Analysis
Stay updated with breaking news from Cytometry System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beckman Coulter Life Sciences, has received 510(k) clearance from (FDA) for AQUIOS STEM System for Stem Cell Analysis
Cell viability is used to measure the proportion of healthy and live cells in a population, and viability assays are done after the injection of an...
/PRNewswire/ -- Flow Cytometry Market is segmented by Type - Cell-Based Flow Cytometry, Bead-Based Flow Cytometry, by Application - Academic & research...
PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.
Creating the industry’s first stem cell analysis update in nearly 25 years, Beckman Coulter Life Sciences – a global leader in laboratory automation and innovation – launches an evolution of the gold standard in hematopoietic stem cell enumeration, the AQUIOS STEM System.